CCCC

C4 THERAPEUTICS INC

Healthcare | Micro Cap

-$0.19

EPS Forecast

$6.95

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-01

Proximilar's AI forecasts

EPS Forecast:

-$0.19

Revenue Forecast:

$6.95

EPS Surprise Forecast:

$0.023

Revenue Surprise Forecast:

$0

Post-release price volatility - Very high

Post-release Overnight Move:

±10.1%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

59%

Probability of beating revenue consensus:

56%

Probability of beating both EPS & revs consensus:

39%

Probability of missing both EPS & revs consensus:

23%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-1

Beta (β)

Forward Looking Beta (β):

2.00

Earnings volatility

EPS standard deviation:

$0.18

Revenue standard deviation:

$10

As % of share price:

6.91%

As % of market cap:

3.89% VERY HIGH

Confidence intervals and percentiles

EPS 95th %ile:

$0.03

Revenue 95th %ile:

$18

EPS 75th %ile:

-$0.13

Revenue 75th %ile:

$10

EPS 25th %ile:

-$0.24

Revenue 25th %ile:

$4

EPS 5th %ile:

-$0.41

Revenue 5th %ile:

-$3

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

35% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

61% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$65

Bid-ask per Share:

$0.015